Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

GeoSolar Technologies Inc. Reinventing the Residential Energy Market

The home energy market represents one of the most overlooked opportunities for sustainable energy investment to dramatically reduce carbon emissions GeoSolar Technologies has developed a patent pending whole-house system using geothermal, solar, and more to transition to energy independent homes The company is preparing a Regulation A+ offering to raise capital ahead With record temperatures […]

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Announces Change in Senior Management as the Company Forwards over 100 BTC on Lightning Network

LQwD has 17 active nodes worldwide on the Lightning Network Current nodes include Italy, Indonesia, Canada, France, Japan, England, Bahrain, South Africa, South Korea, Sweden, Singapore, Hong Kong, Brazil, Germany, India, Ireland, and the United States US-West holds the highest capacity at 5.970784520 BTC and a channel count of 115, followed by France, with a […]

Odyssey Health, Inc. (ODYY), Determined to Introduce the Market’s First FDA Approved Concussion Treatment Drug

PBS News Hour estimates that, for college students, concussions cost between $446 million and $1.5 billion annually, while for high school students the cost ranges from $5.4 billion to $19.2 billion Odyssey, through its flagship product, PRV-002, hopes to offer the first FDA-approved drug treatment for concussions Once approved, Odyssey is confident that PRV-002 will […]

Cub Crafters Inc. Is ‘One to Watch’

CubCrafters owns 15 undeveloped acres at McAllister Field for potential expansion of operations The company recently opened a new 11,000-square-foot Customer Completion Center Cost and timeline of FAA Certification represents a significant barrier to entry The company introduced its CC19-180 XCub aircraft in June 2016, completing the six-year project without using any outside investment The […]

Silo Pharma Inc. (SILO) Produced Initial Liposome Batch for Rheumatoid Arthritis Study

Silo Pharma produced initial batch of SPU-21 liposomes for rheumatoid arthritis study conducted by CRO Frontage Laboratories Recent company research revealed SPU-21 liposomes can target inflamed epithelium, suggesting use for targeted drug delivery SPU-21 can be used for development of fusion imaging molecules and/or nanoparticles to study arthritic pathogenesis Company recently announced positive results in […]

Correlate Infrastructure Partners Inc. (CIPI) Helps Clients Realize ESG Strategies Through Comprehensive Energy Analysis and Environmentally Friendly Upgrades to Facilities

Nearly a decade has passed since approximately 200 government entities met in Paris, ratifying a binding agreement to work toward reducing pollution and its negative impacts on global climate Louisiana-based Correlate Infrastructure Partners is helping to educate corporate clients on both the affordability and potential profit offered by ESG solutions that reduce their greenhouse gas […]

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) Charges Ahead as Clean Tech Company on the Right Track to Providing Optimal Inverter Technology

Hillcrest announces AGM results; all seven members of Board of Directors are re-elected while new board chair David Farrell is appointed Company exits fossil-fuel business and completes transition to clean tech market where it continues to develop inverter technology empowering next generation of more efficient and powerful electric vehicles Hillcrest reaches key milestone as it […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

September 22, 2026

Nearly three million people around the world wake up every day managing a disease that has no cure, and the number keeps climbing. That reality is what makes new approaches to multiple sclerosis worth paying attention to, and it is the space where Quantum BioPharma (NASDAQ: QNTM) is working to make a difference with its […]

Rotate your device 90° to view site.